President Trump’s executive order aims to bring down drug prices while optimizing IP protections, and Congress should pass ...

Learn how antibody to payload design is crucial for advancing ADC technology in oncology and beyond with expert insights.

For small molecule drugs (chemical compounds that are usually pills, e.g. empagliflozin [Jardiance]), prices are negotiated at year 7 and take effect 9 years after FDA approval. For biologics ...

Company enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody New composition of matter IP filed for chemically distinct, orally active, and highly potent small ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

According to a McKinsey analysis, women spend 25% more time than men in poor health — and investments addressing the women’s ...

The large molecule drug substance CDMO market is anticipated to expand at a CAGR of ~9% during the forecast period. Key ...

The biologic excipients market has become a vital component of the pharmaceutical and biotechnology industries, playing a crucial role in the formulation of biologic drugs. These excipients are ...

Radyus Research, a U.S.-based drug development organization, and Eurofins CDMO Alphora, a Canadian contract development and ...

Expansion of Intellectual Property for Novel Small Molecule APJ Agonists BioAge is ... itself as a global pioneer in GPCR innovative biologics discovery. By integrating a world-class GPCR science ...